Application

15835529 · ANTI-CCL17 ANTIBODIES

Filed 2017-12-08 · Granted · Patent 10829549 (2020-11-10) The official file ↗The patent and its PDF ↗ · Art unit 1647 · Examiner Regina M Deberry Hard · CPC A61K 39/395 · Jannsen Biotech, Inc. · Finnegan/GSK

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

9.1 mo

to disposition 35.1 mo

Statutes raised

112

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.